Intarcia’s type 2 diabetes implant more effective than top-seller Januvia, could improve patient adherence
Top-selling diabetes drug Januvia may get a run for its money: Boston-based Intarcia Therapeutics released Phase 3 results saying its implantable device is more effective in treating diabetes and obesity than Januvia.